Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.15 USD
Change Today -0.04 / -1.25%
Volume 42.7K
BVX On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 8:04 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

bovie medical corp (BVX) Key Developments

Bovie Medical Corporation Announces Amendments to Articles of Incorporation

Bovie Medical Corporation announced that it will file a certificate to set out designations, voting powers, preferences, limitations, restrictions, and relative rights of its Series B Convertible Preferred Stock with the Secretary of State of the State of Delaware to amend articles of incorporation. The Certificate of Designations sets out the rights, preferences and privileges of the Series B Preferred Stock. As provided in articles of incorporation, the filing of the Certificate of Designations will be approved by Board of Directors.

Bovie Medical Corporation Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014

Bovie Medical Corporation reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, the company's sales were $7,467,000 compared to $6,128,000 a year ago. Loss from operations was $1,792,000 compared to $875,000 a year ago. Income before income taxes was $703,000 compared to loss before income tax of $3,009,000 a year ago. Net loss was $5,190,000 compared to $2,470,000 a year ago. Net loss attributable to common shareholders was $5,454,000 or $0.39 per diluted share compared to $5,125,000 or $0.29 per diluted share a year ago. Adjusted non-GAAP net loss was $631,000 or $0.04 per basic and diluted share compared to $2,529,000 or $0.14 per basic and diluted share a year ago. For the year, the company's sales were $27,681,000 compared to $23,660,000 a year ago. Loss from operations was $5,849,000 compared to $3,666,000 a year ago. Loss before income taxes was $13,285,000 compared to $5,952,000 a year ago. Net loss was $17,282,000 compared to $4,339,000 a year ago. Net loss attributable to common shareholders was $18,214,000 or $1.03 per basic and diluted share compared to $6,994,000 or $0.40 per basic and diluted share a year ago. Adjusted non-GAAP net loss was $5,328,000 or $0.30 per basic and diluted share compared to $3,753,000 or $0.21 per basic and diluted share a year ago.

Bovie Medical Corporation to Report Q4, 2014 Results on Feb 27, 2015

Bovie Medical Corporation announced that they will report Q4, 2014 results at 9:00 AM, Eastern Standard Time on Feb 27, 2015

Bovie Medical Corporation, Q4 2014 Earnings Call, Feb 27, 2015

Bovie Medical Corporation, Q4 2014 Earnings Call, Feb 27, 2015

Bovie Medical Corporation Provides Update on Recent Developments for J-Plasma

Bovie Medical Corporation provided an update on recent developments for J-Plasma. The company announced that all J-Plasma disposable hand pieces as well as the Bovie Ultimate generator have received CE Mark approval for compliance with European Union safety, health and environmental protection requirements. As a result, the company will be able to sell these devices in the 31 countries of the European Economic Area.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BVX:US $3.15 USD -0.04

BVX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CONMED Corp $51.84 USD -1.56
STAAR Surgical Co $9.30 USD +0.16
Stereotaxis Inc $1.99 USD -0.1599
Vascular Solutions Inc $33.95 USD -1.36
View Industry Companies
 

Industry Analysis

BVX

Industry Average

Valuation BVX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.1x
Price/Book 37.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOVIE MEDICAL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.